Streetbeat News

Stock Prices

BKNG

A significant investor has taken a bearish stance on Booking Holdings (NASDAQ:BKNG), with 60% of recent trades being bearish. The total amount for puts is $68,425 and for calls is $616,994. Whales have been targeting a price range from $2100.0 to $3000.0 for Booking Holdings over the last 3 months. The current price of BKNG is up 1.75% at $2794.28. HSBC has downgraded its action to Buy with a price target of $3650.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

CHK

Chesapeake Energy (NASDAQ:CHK) is set to release its quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.64. The company's stock performance has been generally negative over the last 52-week period, with shares down 17.02%. Last quarter, the company beat EPS estimates by $0.10, but this was followed by a 2.32% drop in the share price.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

BSAC

Banco Santander Chile (NYSE:BSAC) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.43. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $17.48, up 21.49% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.98. The company's past performance shows a pattern of beating EPS estimates. However, the stock has been down 9.55% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

INCY

Incyte (NASDAQ:INCY) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $1.02. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. However, the stock has been down 31.95% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

MSCI

MSCI (NYSE:MSCI) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $3.32. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. MSCI shares were trading at $476.19 as of October 27, with a 1.69% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

ZBRA

Zebra Technologies (NASDAQ:ZBRA) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.81. The company's stock price has historically been affected by its earnings performance and guidance. Last quarter, ZBRA missed EPS by $0.02, resulting in a 5.35% drop in share price. Over the last 52-week period, shares are down 13.27%.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

TECH

Bio-Techne (NASDAQ:TECH) is set to release its quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.44. The company's past performance shows a trend of share price drops following earnings releases. The stock is currently trading at $59.54, down 28.55% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

AMCR

Amcor (NYSE:AMCR) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.15. The company's past performance shows a pattern of beating EPS estimates, which has sometimes resulted in a share price increase. However, the stock has been generally negative over the last 52-week period, with shares down 24.5%.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm

PFE

Pfizer (NYSE:PFE) is set to release its quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $-0.32. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price the following day. Pfizer's shares are currently trading at $30.11, down 36.74% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:01 pm